201 / 236
199
Note 29.7 Fair value measurements
(continued)
(
`
cr)
v)
Assets and liabilities measured
at fair value – recurring fair value
measurements at April 01, 2015
Note
Level 1
Level 2
Level 3
Total
Financial assets
Financial investment at FVPL:
Mutual funds
11
2.66
–
–
2.66
Financial investments at FVOCI:
Quoted equity instruments
6
376.37
–
–
376.37
Unquoted equity instruments
6
–
–
0.03
0.03
Derivatives designated as hedges:
Foreign exchange forward contracts
–
0.01
–
0.01
Currency options
–
0.27
–
0.27
Total financial assets
379.03
0.28
0.03
379.34
Financial liabilities
Derivatives designated as hedges:
Foreign exchange forward contracts
–
0.45
–
0.45
Interest rate swaps
–
0.11
–
0.11
Total financial liabilities
–
0.56
–
0.56
Biological assets
Tissue culture raised date palms
–
7.24
–
7.24
Total biological assets
–
7.24
–
7.24
(
`
cr)
vi) Assets and liabilities for which fair
values are disclosed at April 01,
2015
Note
Level 1
Level 2
Level 3
Total
Financial assets
Investments:
Preference shares
6
5.81
5.81
Government securities
6
0.01
–
–
0.01
Loans
7
–
–
7.88
7.88
Security deposits for utilities and
premises
8
–
–
1.49
1.49
Total financial assets
0.01
–
15.18
15.19
Financial liabilities
Borrowings
17
–
–
293.08
293.08
Security deposits
18
–
–
17.74
17.74
Total financial liabilities
–
–
310.82
310.82
Investment properties
3
–
–
130.00
130.00
There were no transfers between any levels during the year.
Notes
to the Consolidated Financial Statements